Conflicts of Interest The author declares no conflict of interest
Common HCPCS Drug Codes Associated with Injections Many injection claims require both administration coding and HCPCS drug coding
The BNF recently (2019) changed its guidance for the frequency of injections of hydroxocobalamin: Every 2 months in patients who have neurological symptoms Every 2 or 3 months when there are no neurological symptoms
Literature We conducted a systematic review of the case-reports described in the literature [1, 6, 7, 9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34]
Most commercial payers don't require NDC on professional CMS-1500 claims
Research Mechanism In laboratory settings, BPC-157 is utilised to investigate: Angiogenesis: The upregulation of the VEGF (Vascular Endothelial Growth Factor) pathway to promote new blood vessel formation